Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Design and development of caffeic acid conjugated with Bombyx mori derived peptide biomaterials for anti-aging skin care applications

Hoomin Lee a, A. T. Ezhil Vilianb, Jun Yeong Kimc, Myeung Hwan Chund, Jung Sang Suhd, Hyo Hyun Seoc, Seung Hee Choc, Il Soo Shine, Sung Jun Kime, Seok Hoon Parkf, Young-Kyu Han*b, Jeong Hun Lee*c and Yun Suk Huh*ag
aDepartment of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, Republic of Korea. E-mail: yunsuk.huh@inha.ac.kr
bDepartment of Energy and Materials Engineering, Dongguk University-Seoul, Seoul 04620, Republic of Korea. E-mail: ykenergy@dongguk.edu
cAnti-aging Research Institute of BIO-FD&C Co. Ltd., Incheon 22212, Republic of Korea. E-mail: jhlee@biofdnc.com
dDepartment of Chemistry, Seoul National University, Seoul, 151-747, Republic of Korea
eResearch Institute of Charming Cosmetics Co. Ltd., Incheon 22212, Republic of Korea
fIndustry-Academic Cooperation Foundation, Kangnam University, Yongin-si, 16979, Republic of Korea
gWCSL of Integrated Human Airway-on-a-Chip, Inha University, Incheon, Republic of Korea

Received 12th April 2017 , Accepted 31st May 2017

First published on 12th June 2017


Abstract

Over the last few centuries, aging-related diseases have become a part of the global health care problem. The skin is essentially more sensitive to aging because it is influenced by environmental exposure and genetic (genetically determined) processes. The use of a suitable cosmetic anti-aging material using a biomolecule with conventionally important medicine can help to protect damaged skin tissue. A new topical cosmetic anti-aging material should simulate the function of an extracellular matrix with its enhanced physiochemical, biological oxidative stress, and antioxidant properties. This study examined the significant features of CA–APPPKK (caffeic acid conjugated with peptide (APPPKK)) to determine if it meets the requirements for a cosmetic anti-aging biomolecule. Non-toxic CA–APPPKK was synthesized using a simple approach and CA stabilized with a peptide to form the new biomaterials. The cytotoxicity of the CA–APPPKK was examined with a CCK-8 assay and a reactive oxygen species (ROS) assay to evaluate the biological applications. CA–APPPKK caused a decrease in cell viability and membrane damage, and the degree of induction was dose dependent. The longevity-extending role of CA–APPPKK was attributed to its anti-oxidative activity and increased oxidative stress resistance. The anti-inflammatory capacity of CA–APPPKK was measured using a NO assay. This new approach indicates that CA–APPPKK is a potentially cosmetic anti-aging biomaterial for the prevention of oxidative stress-induced premature skin ageing and can be used to study aging-related diseases.


1. Introduction

Aging of the skin is a complex biological process comprising two features: intrinsic aging and photoaging influenced by both environmental (sun radiation, oxidative stress and pollution) and genetic (genetically determined) processes.1,2 In particular, the extreme initiation of reactive oxygen species (ROS) can generate a significant decrease in metabolic function (senescence, apoptotic or necrotic) or cell death, and their presence inside the cell can lead to skin aging.3 Reactive oxygen species play an essential role in initiating the cytoplasmic signal transduction pathways in the tenant fibroblasts and assist in cell growth, differentiation, senescence, and connective tissue degradation, as well as affecting permanent genetic modification.4 Consequently, antioxidant therapy may be a suitable way to reduce the harmful causes of reactive oxygen species and protect the skin from aging.5

Caffeic acid (CA, 3,4-dihydroxycinnamic acid) is a naturally occurring flavonoid molecule found at high concentrations in several plants in many forms, such as glycosides, esters and the free form.6–8 The compound is present in various plant-derived foods, including fruit, black tea, coffee, olive oil, red, and white wines.9 As with other flavonoids, CA has been used widely for various biological activities includes anti-bacterial and antiviral effects, anti-allergic and anti-coagulatory effects, antioxidant and anti-inflammatory activities, anti-mutagenic and anticancer effects and clinical applications because of its biodegradability, biocompatibility, low allergenic properties, and low toxicity.10 Recently, some research groups around the world have been modifying the profile of CA and reported that some CA products have diverse biological activities.11

Bioactive peptides have positive effects in human health and connected functions, including antioxidant activity, antimicrobial activity, angiotensin-I converting enzyme inhibition, and immune modulation. The prepared bioactive peptides have many potential applications in a wide areas, such as cosmetics, food flavors, nutraceuticals, and pharmaceuticals.12 Moreover, bioactive compounds have been studied and used in bio-related areas owing to their excellent structural and biological properties. Bioactive peptides have been applied in many clinical areas over the last 20 years. The active component of caffeic acid contains two vicinal hydroxyl groups on the aromatic ring, known as the catechol group, which imparts stability, surface charges, and allows interactions of the peptide with other molecules.13 The nature of the capping agent affects both the physical properties and biological properties of the peptide.14 The development of eco-friendly and multifunctional caffeic acid–APPPKK biomaterials as free radical scavengers to prevent oxidative damage and reduce toxicity has attracted increasing attention.15 Owing to their antioxidant activity, CA-based peptide biomaterials have been used in a wide range of consumer manufacture, ranging from cosmetics to household products, as well as clinical applications, including imaging, drug delivery and disinfection.16,17 Furthermore, CA-incorporated, APPPKK-impregnated catheters and wound dressings have been applied in the therapeutic applications of tissue engineering and drug delivery.18 On the other hand, earlier studies have reported that biomaterials have size-, time- and dose dependent cytotoxicity, where smaller size nanomaterials with a longer exposure time at higher concentrations have the highest toxicity.19,20 A possible mechanism of the cytotoxicity of caffeic acid–conjugated APPPKK involves a disruption of the mitochondrial respiratory chain, increase in ROS production, and an interruption of ATP synthesis, which in turn causes the oxidation of lipids, proteins and DNA, leading to many disease conditions.21 To the best of the authors' knowledge, this is the first report of the preparation of CA–conjugated APPPKK biomaterials to assess their potential applications in skin tissue engineering and pharmaceutical industry.

A facile, efficient and economical route has been developed to synthesize CA–APPPKK biocompatible materials using APPPKK assisted with CA. CA–APPPKK was characterized by matrix assisted laser desorption/ionization time of flight (MALDI-TOF) and liquid chromatography-mass spectrometry (LC-MS) and the effects of the exposure dose affecting the cell response and cytotoxicity of the prepared CA–APPPKK in human fibroblast cell were studied. The level of toxicity was evaluated using the changes in cell morphology, cell viability and oxidative stress studies. Therefore, the ROS scavenging activity in the skin is important for anti-ageing activity. The CA–APPPKK biomaterials exhibited good fastness properties as well as excellent antioxidant activity. In addition, they played an important role in extending lifespan, and improving oxidative stress resistance. CA supports good antioxidant property. The antioxidant activities were studied using a DPPH antioxidant assay.

2. Materials and methods

2.1. Materials

Fmoc-Ala-OH, Fmoc-Lys (Boc)-OH, and Fmoc-Pro-OH were purchased from Bead-Tech (Seoul, Korea). Fmoc-Lys (Boc)-Wang resin was obtained from Merck (Germany). Hydroxybenzotriazole (HOBt) and N,N′-diisopropylcarbodiimide (DIC) were acquired from GLS (Shanghai, China). Caffeic acid was supplied by 4Chem (Suwon, Korea). Dichloromethane (DCM), dimethylformamide (DMF), and piperidine were procured from Daejung (Siheung, Korea).

2.2. Synthesis of APPPKK and caffeoyl–APPPKK

Fmoc-Lys (Boc)-Wang resin was swelled in dichloromethane (DCM, 5 mL) for 30 min. The resin was filtered and washed with dimethylformamide (DMF). After deprotonation of Fmoc with 20% piperidine in DMF for 20 min or 15 min, Fmoc-Lys (Boc)-OH (3.0 eq.), HOBt (3.0 eq.), and N,N′-diisopropylcarbodiimide (DIC) (3.0 eq.) were added to a NH2-Lys (Boc)-Wang resin (Sub. 0.7 mmol g−1, 0.06 mmol) in DMF. The amino acids were then coupled to the resin by the general HOBt–DIC mediated solid-phase peptide synthesis (SPPS) protocol. After the coupling of the final CA, the resin was filtered, washed, and dried under high vacuum. Finally, the resin was treated with reagent K (TFA[thin space (1/6-em)]:[thin space (1/6-em)]phenol[thin space (1/6-em)]:[thin space (1/6-em)]H2O[thin space (1/6-em)]:[thin space (1/6-em)]thioanisole[thin space (1/6-em)]:[thin space (1/6-em)]EDT = 82.5[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]2.5%) for 3 h. The resin was filtered and washed with DMF and DCM. The collected filtrate was precipitated with pre-cooled ether to give a crude peptide.

Analytical reverse phase high performance liquid chromatography (RP-HPLC) was performed on a Waters 1525u Binary HPLC Pump with a Shimpack RP-C18 column (250 × 4.6 mm ID; 5 μm particle size, Shimadzu). The solvent system consisted of 0.1% TFA in H2O (solvent A) and 0.1% TFA in acetonitrile (solvent B). Elution was achieved by applying a linear gradient from 0% B to 60% B in 30 min. The flow rate was 1.0 mL min−1. The peptide peaks were detected with a Waters 996 Photodiode Array Detector.

Semi-preparative RP-HPLC was performed on a Waters HPLC system (pump 600E, detector UV-484). A Gemini RP-C18 column (250 × 21.2 mm ID; 5 μm particle size, Phenomenex) was used. The solvent system consisted of 0.1% TFA in H2O (solvent A) and 0.1% TFA in acetonitrile (solvent B). Elution was achieved by applying a linear gradient from 5% to 15% B in 15 min. The flow rate was 5.0 mL min−1. The peptide peaks were detected spectrophotometrically (λ = 230 nm).

The molecular weight of the synthesized peptide was analyzed by MALDI-TOF (Voyager, used matrix: α-cyano-4-hydroxy cinnamic acid (CHCA)) mass spectrometry.

The Fourier transform infrared (FT-IR) spectra were acquired using FT/IR-6600, (JASCO).

2.3. Cell culture and viability assay

The human fibroblast cell line (CCD-1064SK, ATCC, USA) was maintained in Dulbecco's Modified Eagles' Media (DMEM; 11965-092, Gibco, USA) supplemented with 10% fetal bovine serum (FBS; 16000044, Gibco, USA) and 1% penicillin–streptomycin (15070063, Gibco, USA). The cells were incubated at 37 °C and 5% CO2. The cell viability after exposure to the different CA–APPPKK was determined using a Cell Counting Kit-8 (CCK-8) assay (CK04-11, Dojindo, Japan). Fibroblast cells were seeded in 12-well cell plates at 1.0 × 104 cells per well and incubated for 24 hours at 37 °C and 5% CO2. After 24 h of cell attachment, the cells were incubated with different concentrations of CA, APPPKK, and CA–APPPKK (1, 10, 50 and 100 μM) for 24 h. The samples were removed and the cells were washed three times with PBS. A 10 μL sample of CCK-8 dye and 100 μL of Dulbecco's Modified Eagle's Medium (DMEM) cell culture media was added to each well and incubated for 2 h at 37 °C. This step was performed to avoid any unwanted scattering from the particles during the absorbance measurements. The absorbance of the supernatant was collected at 420 nm using a SpectraMax Plus 384 microplate reader. The percentage relative cell viability was calculated by normalizing the treated cells to that of the untreated control sample. The medium and MTS reagent without the cells served as a method blank for all samples.

2.4. Detection of reactive oxygen species (ROS) production

2.4.1. Detection of ROS in chemical level. A 100 μL sample of 10 μM DCF-DA (DCF-DA 287810, MERCK MILLIPORE, German) was reacted with 0.01 N NaOH 4 mL for 30 min to achieve complete deacetylation in the darkroom. The mixture solution was then neutralized with PBS 20 mL. Each sample (1, 10, 50, and 100 μM) in PBS with DCF-DA was mixed with HRP (P8375, SIGMA, USA) (2.2 unit per mL) at a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 volumetric ratio and reacted in a darkroom for 30 min. Centrifugation proceeded at 13[thin space (1/6-em)]000 rpm and 4 °C for 10 min. The supernatant solution was moved to a 96 well black plate and the fluorescence intensity of DCF was observed with excitation and emission wavelengths at 485 nm and 535 nm, respectively. The standard curve was obtained from a H2O2 solution.
2.4.2. Detection of ROS in cell level. The generation of ROS was evaluated using 2′,7-dichlorodihydrofluorescein diacetate (H2DCFDA, Invitrogen) staining. In the presence of horseradish peroxidase and H2O2, DCF-DA is converted to highly fluorescent 2′,7′-dichlorodihydrofluorescein (DCF). The ROS assay was performed according to the supplier's instructions. The confluent cells incubated with different concentrations (6.5, 62.5, 125, 250 μM) of CA, APPPKK, and CA–APPPKK for 24 h in 12-well cell plates were treated with 1 mM of H2O2 for 30 min. The cells were twice washed with PBS and incubated with 10 μM DCF-DA for 40 min at 37 °C in the dark. The cells were then washed twice with PBS and analyzed by a microplate reader at an excitation and emission wavelength of 485 nm and 530 nm, respectively.

2.5. Determination of antioxidant activity

A 100 μL sample of DPPH (2,2-diphenyl-1-picrylhydrazyl, D9132, Sigma, USA) at a concentration of 300 μM and 100 μL of APPPKK, CA–APPPKK, and L-ascorbic acid (10300S0301, JUNSEI, Japan) diluted in distilled water to a specific concentration (1, 10, 50, 100 μM) was mixed. The resulting solution was reacted in a dark room at 37 °C for 30 minutes. The solution was measured at 517 nm using a multi plate reader (Varioskan LUX, Thermo Scientific, USA).

2.6. Measurement of NO assay

Macrophage (RAW264.7, KCLB, Korea) cells were cultured in complete DMEM (12100046, Gibco, USA), as described by Chen and Kitts (2015). Briefly, Raw 264.7 cells were seeded on a 12-well cell culture plate (30012, SPL, Korea) at a density of 105 cells per well in complete DMEM and incubated at 37 °C overnight. The cells were pre-treated with the samples in fresh DMEM without FBS for 1 h followed by a treatment with 1.5 g L−1 of sodium bicarbonate, 10% FBS (16000044, Gibco, USA) and 1% penicillin–streptomycin (15070063, Gibco, USA) for a further 24 h to induce NO. The cell culture supernatant (100 μL) was reacted with 100 μL of Griess reagent to form a pink color, which was measured at 517 nm using a multi plate reader (Varioskan LUX, Thermo Scientific, USA).22 Sodium nitrite was used as the standard.

3. Results and discussion

In the present study, we have studied that caffeic acid conjugated with APPPKK (yield 30.2%) having anti-aging effect though oxidant stress prevention. Fig. 1 shows the schematic procedure for the fabrication and application of caffeoyl–APPPKK.
image file: c7ra04138a-f1.tif
Fig. 1 Schematic procedure for the fabrication and application of caffeoyl–APPPKK.

3.1. Characterization studies of CA–APPPKK

This study evaluated the usefulness of MALDI Q-TOF data for protein identification. Here, a direct determination was performed using a MALDI Q-TOF tandem mass spectrometer. As shown in Fig. 2a and b, the measured m/z values were in good agreement with the calculated masses. Fig. 2a and b shows the mass spectrum with a distinct peak at m/z 638.16, revealing the presence of an APPPKK-like peptide. In addition, the peaks at mass 799.80 are possibly due to the presence of a trace amount (0.05%) of a very closely related and structurally similar flavonoid. The high intensity peaks of m/z 799.80 corresponding to the CA–APPPKK confirmed the conclusion of Q in and Chait. This suggests that the immonium ions at m/z 799.80 is a good indicator for CA–APPPKK.23
image file: c7ra04138a-f2.tif
Fig. 2 MALDI-TOF spectrum of (a) APPPKK, (b) CA–APPPKK and (c and d) LC-MS spectrum of the (c) APPPKK, and (d) CA–APPPKK.

High-performance liquid chromatography (HPLC) coupled with a high-resolution quadrupole time-of-flight mass spectrometer (Q-TOF) was used. This technique has advantages over other LC methods because of its high sensitivity and selectivity. Fig. 2c and d shows the LC-MS spectra of the individual compounds. The mass peaks observed in the LC-MS spectra at m/z = 319.50 correspond to APPPKK and at m/z = 400.50 correspond to CA. Therefore, the high intensity peak is identified as CA–APPPKK. In addition, the compounds were confirmed by comparing the Fig. 2c and d with the corresponding LC-MS spectra of the standard.24

The modification of CA with APPPKK was observed during the synthesis of the CA–APPPKK by quadrupole-time of flight (TOF) mass spectrometry. The peptide fragment ions obtained from doubly charged precursors produced by nanoelectrospray were mainly y-type ions with some b-ions in the lower mass range. The ratio and intensity of these fragment ions was found to be strongly sequence dependent for MALDI generated ions. The singly charged peptides generated by MALDI showed the preferential cleavage of the C-terminal bond of acidic residues CA and the N-terminal bond of APPPKK. As expected, the quadrupole-time of flight (TOF) mass spectrum of CA–APPPKK showed two additional peak series (b, and y). Their calculated masses were in good agreement with the experimental data, as shown in Fig. 3a. In the high mass region, some unresolved broad signals appear, but are not interpretable in terms of providing sequence-specific information. A possible readout consists of ions that are annotated as b1 to b6, which would give rise to the sequence tag CA, CA–A, CA–AP, CA–APP, CA–APPP, and CA–APPPK. The excellent signal-to-noise ratio and notable observation of the non-preferential cleavage product ions y1 to y6 caused the further exploration of low intensity signals in the spectrum of doubly charged K, KK, PKK, PPKK, PPPKK, and APPPKK. Additional sequence information might be obtained if sufficient numbers of doubly charged CA–APPPKK precursor ions can be generated. The observation of those peaks provides sufficient information to obtain a sequence tag and identify the CA–APPPKK peptide.


image file: c7ra04138a-f3.tif
Fig. 3 (a) Quadrupole-time of flight (TOF) spectrum of CA–APPPKK, (b) FTIR spectra of CA, APPPKK, and CA–APPPKK.

The FTIR spectrum of the prepared APPPKK, CA and CA–APPPKK are presented in Fig. 3b. The FTIR spectra of pure CA, APPPKK and CA–APPPKK were also measured for comparative analysis. The pure CA sample shows strong signals at 3424 cm−1 (–O–H stretching vibration), 3240 cm−1 (benzene ring [double bond, length as m-dash]C–H stretching vibration), 1523 cm−1 (benzene ring C[double bond, length as m-dash]C stretching vibration), 1221 cm−1 (C–OH stretching vibration of phenol), 1642 and 1620 cm−1 (antisymmetry and symmetrical stretching vibrations C[double bond, length as m-dash]O in the ester group (O[double bond, length as m-dash]C–O)). The above result confirms the structure of caffeic acid.25 Both APPPKK and CA–APPPKK exhibited signals at 1600–1689, 1479–1573, 1226–1303, and 640–800 cm−1. We observed that the FTIR spectra of CA and CA–APPPKK show the disappearance of the O–H vibration attached to the benzene ring and the formation of a new broad signal at 3394 cm−1. Previous report according to that the H-bonded OH stretch normally occurred as broad spectra in the region 3200–3570 cm−1 due to hydrogen bond interactions. These results confirm the interaction between CA and APPPKK. Moreover, the CA characteristic peak were less prominent in CA–APPPKK, compared to the peaks observed in caffeic acid spectrum.26

3.2. Cell viability assay

Cell viability assays are significant for identifying toxicity by showing the cellular response to a toxic chemical and providing details of cell death, survival, and metabolic activities. The cytotoxicity of the various concentrations of CA, APPPKK and CA–APPPKK (dose range 12.5–100 μM) on the viability of fibroblast cells was determined by a cell counting kit-8 (CCK-8) assay at 24 h (Fig. 4a). A significant dose dependent decrease in the percentage of viable cells exposed to CA was observed. Moreover, a previous study reported that some polyphenols of CA (hydroxycinnamate group) can inhibit the growth of fibroblast cells.27 These results show that low concentrations of CA have a cytostatic effect, while high concentrations of CA cause cytotoxicity. In contrast, cytotoxicity of APPPKK and CA conjugated with APPPKK, was lower than that with CA alone. When the concentration was improved to 100 μM, the cell viability was still above 90% for the CA–APPPKK samples, indicating the low toxicity and excellent biocompatibility of the CA–APPPKK. The results could open an avenue in CA conjugated with APPPKK used as a safe probe for in vivo and biomedical applications.28
image file: c7ra04138a-f4.tif
Fig. 4 (a) Cytotoxicity of fibroblast cell treated with APPPKK, CA–APPPKK, and CA at different concentrations (12.5, 25, 50 and 100 μM) for 24 h was determined using the CCK-8 assay method. (b) ROS generation monitored using APPPKK, CA–APPPKK, and CA at different concentrations (1, 10, 50 and 100 μM). (c) Quantification using the standard curve of H2O2. (d) ROS scavenging monitored using APPPKK, CA–APPPKK, and CA at different concentrations of (1, 10, 50 and 100 μM) in fibroblast cell.

3.3. ROS production of CA–APPPKK

Reactive oxygen species (ROS) are considered signaling molecules participating in many cellular functions, including cell proliferation, differentiation, and apoptosis. To evaluate the endogenous ROS production in the chemical level with CA, APPPKK, and CA–APPPKK, 2′,7-dichlorodihydrofluorescein diacetate (H2DCFDA) staining was performed at the chemical level. H2DCF-DA is an indicator of ROS, which is non-fluorescent until the acetate groups are removed by oxidation.29 The ROS level was increased by L-ascorbic acid in a dose-dependent manner (1, 10, 50 and 100 μM) (Fig. 4b). When the concentration was below 100 μM, the ROS levels induced by L-ascorbic acid were 11 times higher than the CA–APPPKK. Overall, the applied doses of CA, APPPKK and CA–APPPKK (1, 10, 50 and 100 μM) did not show any obviously ROS generation compared to the control sample. Fig. 4c represents the value of Fig. 4b quantitatively from the standard curve of H2O2. Therefore, CA–APPPKK has potential applications in skin tissue regeneration and wound healing therapeutics.

3.4. Inhibition of ROS production

In the present study, the influence of CA, APPPKK, and CA–APPPKK (dose range 6.25–250 μM) on the intracellular antioxidant enzyme activities of HRP in fibroblast cells with H2O2 induced oxidative stress was examined to determine if the intracellular ROS scavenging capacities of CA, APPPKK and CA–APPPKK were associated with a modulation of the endogenous antioxidant defense systems. Under normal and oxidative stress conditions, there are sophisticated antioxidant defense systems to eliminate the excess ROS in cells and issues. For example, HRP converts H2O2 to H2O. The biomaterial characteristics can culminate in ROS generation, which is responsible for CA–APPPKK toxicity. The 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA) techniques were achieved for 24 h to examine the role of ROS in fibroblast cells with APPPKK, CA–APPPKK, and L-ascorbic acid in the presence of H2O2 (Fig. 4d). In addition, CA–APPPKK reduced the H2O2 concentration dramatically after 24 h at all concentrations, demonstrating that CA (hydroxycinnamate group) in CA–APPPKK undergo H2O2-mediated oxidation. Surprisingly, the ROS production of CA–APPPKK in fibroblast cells was more pronounced than that of L-ascorbic acid, which was corroborated by the viability results. Moreover, L-ascorbic acid showed higher ROS values than the APPPKK and CA–APPPKK in the presence of H2O2. Under these experimental conditions, CA–APPPKK can reduce the generation of ROS and exert anti-inflammatory activity in the presence of H2O2. These results show that CA–APPPKK reacted with overproduced H2O2 and exerted extremely effective anti-inflammatory activities that reduced or inhibited the larger generation of ROS and cellular damage. Therefore, CA–APPPKK have remarkable ROS scavenger ability as bio-therapeutic agents or upregulated to protect the cells from oxidative stress-induced damage and H2O2-associated diseases.

3.5. UV protection effect of CA–APPPKK

To understand the influence of the cytotoxicity on the CA–APPPKK sample, the cellular morphology of the untreated and treated samples was monitored by optical microscopy. The cellular morphological changes were due mainly to UVB radiation. First, HaCaT was treated with 100 mJ cm−2 UVB. After UVB irradiation, cellular images were found 12 hours after treatment with CA–APPPKK (100 μM) and L-ascorbic acid (100 μM), respectively (Fig. 5). Compared to the untreated cells (negative control), the cells treated with UVB showed a significant irradiation-induced decrease in cell viability even after 12 hours of incubation (Fig. 5b). When L-ascorbic acid (100 μM) was added to the HaCaT cells promptly after irradiation (Fig. 5c), L-ascorbic acid did not protect against UVB irradiation-inhibited cell viability. CA–APPPKK had a protective effect on UVB-induced cell death when added to HaCaT cells promptly after irradiation (Fig. 5d). The CA–APPPKK (100 μM) treatment with UVB resulted in decreased cytotoxicity in HaCaT cells compared to that induced by the UVB-irradiation alone or with L-ascorbic acid. These results confirm that CA–APPPKK is less cytotoxic to human skin keratinocytes (HaCaT). Overall, the as-prepared CA–APPPKK with valuable biocompatibility could be applied as a favorable biomaterial in biomedical fields, particularly in personal skin-care field.
image file: c7ra04138a-f5.tif
Fig. 5 Cell viability of HaCaT cells (human skin keratinocytes) stimulated with (a) control untreated cells, (b) only UVB, (c) cells treated with 100 μM of L-ascorbic acid, (d) cells treated with 100 μM of CA–APPPKK for 24 h; scale bar = 150 μm.

3.6. DPPH assay

The DPPH radical scavenging activity assay is a simple and fast way to determine the antioxidant activity of most bio substances tested in this study. This assay is based on the election transfer (ET) reaction, which causes the purple DPPH reagent to turn colorless when an antioxidant donates electrons and hydrogen atoms.30 The antioxidant activity of L-ascorbic acid, APPPKK, and CA–APPPKK was evaluated using the ‘DPPH radical scavenging method’. APPPKK had the lowest DPPH radical scavenging activity of 10.0%, whereas CA–APPPKK had the highest antioxidant activity of 87.3% at 100 μM (Fig. 6a). CA is hydrophobic and insoluble in water, whereas APPPKK is highly soluble. By conjugating CA with APPKK, the composite becomes soluble in water due to the formation of an amide bond between CA and APPPKK through covalent linkage. Also the CA–APPPKK compound will exhibit antioxidant property while adding the antioxidant rich CA with APPPKK. The final product is soluble and showing excellent antioxidant property which is biodegradable and biocompatible. In this study, it is speculated that a maximum CA–APPPKK concentration of 100 μM could increase the antioxidant activity, preventing H2O2-induced DNA damage as well as the generation of lipid peroxidation products, and it could suppress inflammatory reactions in RAW264.7 cells.
image file: c7ra04138a-f6.tif
Fig. 6 (a) DPPH radical anti-oxidant activity of different biomaterials at different concentrations of APPPKK, CA–APPPKK, and L-ascorbic acid (1, 10, 50 and 100 μM) for 24 h. (b) Storage stability of the antioxidant activity (% scavenging) activity of APPPKK, and CA–APPPKK. (c) Anti-inflammatory assay (NO assay) assay for various surface functionalized lipopolysaccharide (LPS) L-NMMA, APPPKK, and CA–APPPKK at different concentrations in Raw 264.7 macrophages, respectively. (d) NO production by Raw 264.7 macrophages upon 24 h treatment with different biomaterials at different concentrations of APPPKK, CA–APPPKK, and L-ascorbic acid (1, 10, 50 and 100 μM). NO production was measured using Griess assay.

3.7. Long term stability assay

A significant indicator of the long-term stability of the antioxidant activity (% scavenging) is the influence of APPPKK, and CA–APPPKK under various storage periods (1 to 5 weeks). APPPKK showed the lowest antioxidant ability of 4.89% for 5 weeks. The antioxidant activity of the CA–APPPKK showed higher antioxidant activity of 87.26% and 83.69% respectively, for 5 weeks compared to L-ascorbic acid. Moreover, the resulting vitamin C showed a gradual decrease in antioxidant activity over 5 weeks, which gave a lower antioxidant ability of 2.89% (Fig. 6b). The antioxidant activity of the CA–APPPKK remained unchanged for 5 weeks at room temperature. Because of the good polyphenol storage stability at this temperature, the CA–APPPKK revealed excellent antioxidant activity, which remained unchanged throughout the 5 weeks of storage. Previous studies correlated the reducing capacity of phenolic compounds to their electron-donating ability.5 Therefore, the effective electron (hydrogen) donating ability of the CA–APPPKK is believed to have contributed to the overall observed antioxidant property.

3.8. NO assay

Nitrite is a well-known highly toxic substance and bioactive free radical produced during inflammatory events and it plays a key role in several biological and pathological conditions.4 The anti-inflammatory effect of NG-methyl-L-arginine acetate salt (L-NMMA, dose 20 nM), APPPKK, and CA–APPPKK (dose range 1–100 μM) on the production of NO of Raw 264.7 macrophages was determined using a Griess assay at 24 h (Fig. 6c). The stimulation of RAW264.7 cells with lipopolysaccharide (LPS, dose 1 μg mL−1) led to a significant increase in the continuous production of NO, which may lead to DNA damage, disruption of DNA repair, and cancer after translational modification. Incubating the cells with L-NMMA inhibited the production of NO in cultured cells. To examine the anti-inflammatory effects of APPPKK, and CA–APPPKK, this study examined whether the LPS-induced inflammatory responses in RAW264.7 cells can be inhibited by CA–APPPKK. The Raw 264.7 macrophages treated with (1, 10, 50 and 100 μM) of CA–APPPKK showed decreased NO production compared to that of LPS-treated cells. These results also suggest that CA–APPPKK may act as an anti-inflammatory agent with a good safety profile for both skin care and wound therapies.

Fig. 6d shows the influence of LPS, L-NMMA, APPPKK and CA–APPPKK (dose range 1–100 μM) on the inflammatory activity. Interestingly, the results showed that NO production was induced by a treatment with LPS. Among the four biomaterials, LPS was the most powerful, inducing a 600% increase in nitrite production by the LPS-activated RAW264.7 cells. L-NMMA and APPPKK showed no significant nitrite production at different concentrations (1–100 μM) in the Raw 264.7 cell. Exposure to 100 μM of CA–APPPKK did not cause an inflammatory response and it had a slightly inhibitory effect on the inflammatory response (Fig. 6d), which was maintained at a similar value to that of the control samples. These results indicate that CA–APPPKK, containing phenolic compounds (CA), can scavenge oxygen free radicals and NO radicals by different antioxidant models.

4. Conclusion

This paper reported a facile and inexpensive approach for the conjugation of caffeic acid with APPPKK peptide. The fabricated CA–APPPKK was characterized physio-chemically using MALDI-TOF and HPLC-MS. The cytotoxicity results clearly indicated that CA–APPPKK does not have cytotoxic effects on the human cell line. In addition, CA–APPPKK exhibited interesting dose-dependent antioxidant and free radical scavenging activities. CA–APPPKK possesses effective antioxidant activity, which includes free radical and superoxide anion radical scavenging and reducing power. This study investigated ROS generation from various CA–APPPKK surfaces and showed that surface functionalization is the key factor influencing ROS generation and biomaterials toxicity. Such a fabrication approach of CA–APPPKK provides an efficient shape control and cost-effective approach that is potentially competitive for scaling-up to industrial production. This approach highlights the potential of caffeic acid conjugated with APPPKK in skin care and wound healing applications.

Acknowledgements

This study was supported by a grant of the Korea Industrial Complex Corp. (KICOX, No. RIC16001). This work was also supported by Inha University WCSL research grant, Korea.

References

  1. H. Wen, X. Gao and J. Qin, Integr. Biol., 2013, 6, 35–43 RSC.
  2. G. R. Boss and J. E. Seegmiller, West. J. Med., 1981, 135, 434–440 CAS.
  3. D. B. Kim, G. H. Shin, J. M. Kim, Y. H. Kim, J. H. Lee, J. S. Lee, H. J. Song, S. Y. Choe, I. J. Park, J. H. Cho and O. H. Lee, Food Chem., 2016, 194, 920–927 CrossRef CAS PubMed.
  4. R. P. Singh, S. Sharad and S. Kapur, J. Indian Acad. Clin. Med., 2004, 5, 218–225 Search PubMed.
  5. Y. C. Hseu, W. H. Chang, C. S. Chen, J. W. Liao, C. J. Huang, F. J. Lu, Y. C. Chia, H. K. Hsu, J. J. Wu and H. L. Yang, Food Chem. Toxicol., 2008, 46, 105–114 CrossRef CAS PubMed.
  6. V. S. Chedea, L. Choueiri, M. Jisaka and P. Kefalas, Food Chem., 2012, 135, 1999–2004 CrossRef CAS PubMed.
  7. N. Oršolić, M. Kunštić, M. Kukolj, R. Gračan and J. Nemrava, Chem.-Biol. Interact., 2016, 256, 111–124 CrossRef PubMed.
  8. A. T. E. Vilian, S.-M. Chen, Y.-H. Chen, M. A. Ali and F. M. A. Al-Hemaid, J. Colloid Interface Sci., 2014, 423, 33–40 CrossRef PubMed.
  9. İ. Gülçin, Toxicology, 2006, 217, 213–220 CrossRef PubMed.
  10. J. H. Chen and C. T. Ho, J. Agric. Food Chem., 1997, 45, 2374–2378 CrossRef CAS.
  11. M. G. Ignatova, N. E. Manolova, I. B. Rashkov, N. D. Markova, R. A. Toshkova, A. K. Georgieva and E. B. Nikolova, Mater. Sci. Eng., C, 2016, 65, 379–392 CrossRef CAS PubMed.
  12. A. A. Lozano-Pérez, H. C. Rivero, M. d. C. Pérez Hernández, A. Pagán, M. G. Montalbán, G. Víllora and J. L. Cénis, Int. J. Pharm., 2017, 518, 11–19 CrossRef PubMed.
  13. Y. Sato, S. Itagaki, T. Kurokawa, J. Ogura, M. Kobayashi and T. Hirano, Int. J. Pharm., 2011, 403, 136–138 CrossRef CAS PubMed.
  14. Y. Li, F. Jiang, L. Chen, Y. Yang, S. Cao, Y. Ye, X. Wang, J. Mu, Z. Li and L. Li, FEBS Open Bio, 2015, 5, 466–475 CrossRef CAS PubMed.
  15. M. F. Tolba, H. A. Omar, S. S. Azab, A. E. Khalifa, A. B. Abdel-Naim and S. Z. Abdel-Rahman, Crit. Rev. Food Sci. Nutr., 2016, 56, 2183–2190 CrossRef CAS PubMed.
  16. S. Yu, H. Hsieh, J. Pang, D. Tang, C. Shih and M. Tsai, Food Hydrocolloids, 2013, 32, 9–19 CrossRef CAS.
  17. G.-W. Oh, S.-C. Ko, J.-Y. Je, Y.-M. Kim, J. Oh and W.-K. Jung, Int. J. Biol. Macromol., 2016, 93, 1549–1558 CrossRef CAS PubMed.
  18. T. T. Cao and Y. Q. Zhang, Mater. Sci. Eng., C, 2016, 61, 940–952 CrossRef CAS PubMed.
  19. M. Yan, J. Du, Z. Gu, M. Liang, Y. Hu, W. Zhang, S. Priceman, L. Wu, Z. H. Zhou, Z. Liu, T. Segura, Y. Tang and Y. Lu, Nat. Nanotechnol., 2010, 5, 48–53 CrossRef CAS PubMed.
  20. L. Yang, Z. Zheng, C. Qian, J. Wu, Y. Liu, S. Guo, G. Li, M. Liu, X. Wang and D. L. Kaplan, J. Colloid Interface Sci., 2017, 496, 66–77 CrossRef CAS PubMed.
  21. M. V. Blagosklonny, Drug Discovery Today, 2007, 12, 218–224 CrossRef CAS PubMed.
  22. S. J. Green, M. S. Meltzer, J. B. Hibbs and C. A. Nacy, J. Immunol., 1990, 144, 278–283 CAS.
  23. Z. Liu and K. L. Schey, J. Am. Soc. Mass Spectrom., 2005, 16, 482–490 CrossRef CAS PubMed.
  24. S. M. Mandal and S. Dey, J. Biomol. Tech., 2008, 19, 116–121 Search PubMed.
  25. Y. Xing, H. Peng, M. Zhang, X. Li, W. Zeng and X. Yang, J. Zhejiang Univ., Sci., B, 2012, 13, 487–493 CrossRef CAS PubMed.
  26. A. Belay, H. K. Kim and Y.-H. Hwang, Luminescence, 2016, 31, 565–572 CrossRef CAS PubMed.
  27. J. M. Glamoclija, J. Sci. Food Agric., 2013, 93, 3205–3208 CrossRef PubMed.
  28. T. Arai, A. Ohno, K. Mori, H. Kuwata, M. Mizuno, K. Imai, S. Hara, M. Shibanuma, M. Kurihara, N. Miyata, H. Nakagawa and K. Fukuhara, Bioorg. Med. Chem. Lett., 2016, 26, 5468–5471 CrossRef CAS PubMed.
  29. I. Rosenthal and E. Ben-Hur, Int. J. Radiat. Biol., 1995, 67, 85–91 CrossRef CAS PubMed.
  30. D. B. Kim, G. H. Shin, Y. J. Lee, J. S. Lee, J. H. Cho, S. O. Baik and O. H. Lee, Food Chem., 2014, 151, 58–64 CrossRef CAS PubMed.

Footnotes

Electronic supplementary information (ESI) available. See DOI: 10.1039/c7ra04138a
Three authors equally contributed.

This journal is © The Royal Society of Chemistry 2017